Tocilizumab-induced Leukoencephalopathy with a Reversible Clinical Course

Tocilizumab (TCZ; Actemra/RoActemra) is an anti-interleukin (IL)-6 receptor antibody for the treatment of rheumatoid arthritis (RA) and other autoimmune diseases and cytokine storms. The present case is a 63-year-old female well-controlled RA patient, who presented with a progressive cognitive impai...

Descripción completa

Detalles Bibliográficos
Autores principales: Sasaki, Ryo, Hishikawa, Nozomi, Nomura, Emi, Omote, Yoshio, Takemoto, Mami, Yamashita, Toru, Hatanaka, Noriko, Higashi, Yasuto, Abe, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725625/
https://www.ncbi.nlm.nih.gov/pubmed/32999229
http://dx.doi.org/10.2169/internalmedicine.5288-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725625/
https://www.ncbi.nlm.nih.gov/pubmed/32999229
http://dx.doi.org/10.2169/internalmedicine.5288-20

Ejemplares similares